However, while SOD1G93A rodents are a well-established model for ALS research, SOD1 mutations account for only a small fraction of human ALS cases, and many therapies that showed promise in this model have failed in clinical trials [69]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.